Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #4270 on Antares Pharma, Inc. (ATRS)
H2R
10/09/17 10:03 AM
#4271 RE: Frauddoc #4270
In view of the foregoing, it is fair to assume that an AB-rated version of the epinephrine injection, marketed by a well-known generic supplier like Teva, will be welcomed by prescribing doctors. In addition, due to a high level of public outrage with Mylan, it is fair to assume that consumers will react very favorably to a new, therapeutically equivalent, EpiPen alternative that can be substituted in prescriptions.